Page last updated: 2024-12-08
rosenthal's inhibitor
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Rosenthal's inhibitor: RN given refers to acetate salt; inhibits phopholipases A1 and A2 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 160880 |
SCHEMBL ID | 7453596 |
MeSH ID | M0064239 |
Synonyms (23)
Synonym |
---|
rosenthal's inhibitor |
7059-39-4 |
n-(2-hydroxyethyl)-n,n-dimethyl-2,3-bis(octadecanoyloxy)propan-1-aminium acetate |
niosh/bp8243850 |
dl-2,3-distearoyloxypropyl(dimethyl)-beta-hydroxyethylammonium acetate |
ammonium, (2,3-dihydroxypropyl)dimethyl(2-hydroxyethyl)-, acetate, distearate, dl- |
BP82438500 |
dimethyl dl-2,3-distearoyloxypropyl-2'-hydroxyethylammonium acetate |
1-propanaminium, n-(2-hydroxyethyl)-n,n-dimethyl-2,3-bis((1-oxooctadecyl)oxy)-, acetate (salt) |
(2,3-dihydroxypropyl)(2-hydroxyethyl)dimethylammonium distearate acetate |
dimethyl-dl-2,3-distearoyloxypropyl-2'-hydroxyethylammonium acetate |
dimethyl-2,3-distearolyoxypropyl-2'-hydroxylethylammonium acetate |
1-propanaminium, n-(2-hydroxyethyl)-n,n-dimethyl-2,3-bis((1-oxooctadecyl)oxy)-, (+-)-, acetate (salt) |
13106-14-4 |
dds-acetate |
dimethyl-dl-2,3-distearoyloxypropyl(2-hydroxyethyl)ammonium acetate |
SCHEMBL7453596 |
DTXSID10276491 |
106545-38-4 |
J-005929 |
2,3-di(octadecanoyloxy)propyl-(2-hydroxyethyl)-dimethylazanium;acetate |
1-propanaminium, n-(2-hydroxyethyl)-n,n-dimethyl-2,3-bis[(1-oxooctadecyl)oxy]-, acetate (1:1) |
n-(2-hydroxyethyl)-n,n-dimethyl-2,3-bis(stearoyloxy)propan-1-aminium acetate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.92
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.92) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |